CEREBIS Trademark

Trademark Overview


On Thursday, April 20, 2023, a trademark application was filed for CEREBIS with the United States Patent and Trademark Office. The USPTO has given the CEREBIS trademark a serial number of 79371653. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, September 6, 2024. This trademark is owned by KNIGHT THERAPEUTICS EUROPE S.A.. The CEREBIS trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human use
cerebis

General Information


Serial Number79371653
Word MarkCEREBIS
Filing DateThursday, April 20, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, September 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKNIGHT THERAPEUTICS EUROPE S.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressLU

Trademark Events


Event DateEvent Description
Monday, June 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 18, 2024ASSIGNED TO EXAMINER
Thursday, June 8, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 16, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, January 31, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2024REFUSAL PROCESSED BY IB
Friday, September 6, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, September 6, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 21, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 1, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 21, 2024REFUSAL PROCESSED BY MPU

Related Keywords


cerebis human medicines